NHS Framework - Blood Disorders including Haemophilia A and B - July 2024
NHS England
This tender has closed
The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
NHS England awarded this contract to Pfizer Ltd | Roche Products Ltd | Novo Nordisk | Sobi (Swedish Orphan Biovitrum Ltd) | Takeda UK Ltd | LFB | Bio Products Laboratory Ltd | Octapharma Limited | CSL Behring UK Ltd worth £765,000,000 on 31 May 2024. The contract runs until 30 Apr 2027.
Description
Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024
Offer reference number: CM/PHS/22/5661
Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Awarded suppliers (9)
- Pfizer Ltd
- Roche Products Ltd
- Novo Nordisk
- Sobi (Swedish Orphan Biovitrum Ltd)
- Takeda UK Ltd
- LFB
- Bio Products Laboratory Ltd
- Octapharma Limited
- CSL Behring UK Ltd
Contact
Identifiers
Explore related tenders
Other tenders from NHS England
View all →External ID: cf-ocds-b5fd17-78480ca7-506a-4fbd-ab2d-b535c8904519 • Added 3 October 2026